Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.

Yazdany, Jinoos; Kim, Alfred H J

Yazdany, Jinoos; Kim, Alfred H J.

Yazdany J; Zuckerberg San Francisco General Hospital, University of California, San Francisco, California (J.Y.).
Kim AHJ; Washington University School of Medicine, St. Louis, Missouri (A.H.K.).

Ann Intern Med ; 172(11): 754-755, 2020 06 02.

Article in English | MEDLINE | ID: covidwho-2144990

Subject(s)

Chloroquine/therapeutic use; Coronavirus Infections/drug therapy; Hydroxychloroquine/therapeutic use; Pneumonia, Viral/drug therapy; Rheumatic Diseases/drug therapy; Betacoronavirus; COVID-19; Chloroquine/supply & distribution; Drug Repositioning; Humans; Hydroxychloroquine/supply & distribution; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; COVID-19 Drug Treatment

Keywords

Antimalarials; Blood plasma; COVID-19; Chloroquine; Clinical trials; Decision making; Drugs; Lupus erythematosus; Metastasis; Pulmonary diseases

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Chloroquine / Rheumatic Diseases / Coronavirus Infections / Hydroxychloroquine Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Ann Intern Med Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google